New EC GMP regulations for radiopharma
Revised good manufacturing practice (GMP) requirements for the production of radiopharmaceuticals have been published by the European Commission (EC).
Archives for September 14, 2008
Agilent and Millipore join forces to further epigenetics research
Agilent and Millipore have formed a collaboration to develop fully validated chromatin immunoprecipitation (ChIP) microarray kits that will improve productivity and streamline epigenetic analysis.
Nanoparticle made for delivering combination therapies
A nanoparticle capable of carrying a soluble and insoluble drug has been created for the delivery of combination therapies, according to research published in Nature.
Fresenius’ APP expands Grand Island capacity
APP Pharmaceuticals has bought additional facilities at a site in Grand Island, New York seizing the opportunity created by Astellas Manufacturing’s decision to shift production of its dermatitis drug Protopic to Japan.
MonoSol film technology gets US protection
US drug delivery specialist MonoSol Rx says it has received USPTO patent rights to processes used in the manufacture of PharmFilm, its proprietary thin film drug delivery technology.
Quintiles gets bigger in Singapore to continue Asian push
Quintiles Transnational Corp has announced an expansion of its operations in Singapore in order to meet what it described as “surging demand” in the Asia-Pacific region.
Alcan Packaging may break-up after year on the shelf
Speculation is rife that Australia’s Amcor is one of several companies to have tabled bids for Rio Tinto’s $4.4bn (€3.1bn) Alcan Packaging division that serves the pharmaceutical, food and tobacco industries.
Fluorotechnics expands into the US with GelCo buy
Australian proteomics fluorescence expert Fluorotechnics has agreed to buy The Gel Company as part of its strategy to cement itself as a world leader in protein electrophoresis.
Takeda pursues CMO in court for $26.7m
Takeda Pharmaceutical has filed a lawsuit in an attempt to recoup $26.7m in damages, after it had to recall a product made by a contract manufacturing organisation (CMO).
Boom times continue for Indian CMOs
India’s contract manufacturing market is expected to rocket forward over the next couple of years to reach a value of $2.46bn in 2010, according to a just-released report from KPMG.
BMS gets closer to Accenture with $550m IT deal
Pharmaceutical major Bristol-Myers Squibb has signed another deal with outsourcing specialist Accenture, this time tapping the firm for IT and financial support services via a 10-year contract worth $550m.
PharmaNet slumps on another ‘08 earnings cut
Drug development services company PharmaNet saw its share price slashed in half on Friday after downsizing its 2008 revenues and earnings forecasts for the second time this year.